Won J Y, Lee D Y, Shim W H, Chang B C, Park S I, Yoon C S, Kwon H M, Park B H, Jung G S
Department of Diagnostic Radiology, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea.
J Vasc Interv Radiol. 2001 May;12(5):575-82. doi: 10.1016/s1051-0443(07)61478-x.
To report our experience of endovascular stent-graft placement in patients with descending thoracic aortic dissections and aneurysms and to evaluate the feasibility, safety, and clinical outcomes of the treatment.
Stent-grafts were placed in the descending thoracic aortas of 23 patients with saccular aneurysms (n = 11) and Stanford type B chronic aortic dissections of the descending thoracic and abdominal aorta (n = 12). All stent-grafts were individually constructed of self-expandable stainless steel stents covered with polytetrafluoroethylene. Vascular access was achieved through the femoral artery in all patients. Clinical status of each patient was monitored and postoperative CT was performed within 1 month of the procedure and at 3-12-month intervals after the procedures.
Successful exclusion of the primary entry tears of dissections and the inlets of saccular aneurysms was achieved in all but two patients with aortic dissection. The overall technical success rate was 91.3% (dissection: 10 of 12 = 83%; aneurysm: 11 of 11 = 100%). All patients in whom technical success was achieved showed complete thrombosis and significant decrease in diameter of the thoracic false lumen (preoperative: 5.3 cm +/- 0.9; postoperative: 4.3 cm +/- 0.9; P = .004) or aneurysm sac (preoperative: 5.3 cm +/- 1.7; postoperative: 2.8 cm +/- 2.5; P = .001). In addition, five patients demonstrated complete resolution of the dissected thoracic false lumen (n = 2) and aneurysm sac (n = 3). However, in all patients with aortic dissection, the abdominal aorta was not significantly changed in size (P = .302) and shape and their false lumen flows remained persistent. Immediate postoperative complications were detected in 12 patients (52%); 10 had fever, leukocytosis, and elevation of C-reactive protein, another had wound infection, and another had transient abdominal pain. Three patients died 2, 3, and 12 months after the procedure: one from septic shock, another from underlying mediastinitis, and the other from an unexplained cause. The remaining 20 patients were well after the procedure (1-9 days; mean, 3 days), without any stent-graft-related complications or discomfort (follow up period: 10-65 mo; mean: 25.1 mo +/- 15.6). The cumulative survival rate after the stent graft was 100% at 30 days and 91% at 12 months.
For treatment of aortic dissection and saccular aneurysm of the descending thoracic aorta, endovascular stent-graft repair may be a technically feasible and effective treatment modality.
报告我们在降主动脉夹层和动脉瘤患者中进行血管内支架移植物置入的经验,并评估该治疗方法的可行性、安全性和临床疗效。
对23例患有囊状动脉瘤(n = 11)以及降主动脉和腹主动脉的斯坦福B型慢性主动脉夹层(n = 12)的患者,在其降主动脉中置入支架移植物。所有支架移植物均由覆盖有聚四氟乙烯的自膨胀不锈钢支架单独构建而成。所有患者均通过股动脉实现血管通路。对每位患者的临床状况进行监测,并在术后1个月内及术后3 - 12个月间隔进行CT检查。
除2例主动脉夹层患者外,所有患者均成功封闭了夹层的原发破口和囊状动脉瘤的入口。总体技术成功率为91.3%(夹层:12例中的10例 = 83%;动脉瘤:11例中的11例 = 100%)。所有技术成功的患者均显示完全血栓形成,胸段假腔直径显著减小(术前:5.3 cm ± 0.9;术后:4.3 cm ± 0.9;P = .004)或动脉瘤囊直径显著减小(术前:5.3 cm ± 1.7;术后:2.8 cm ± 2.5;P = .001)。此外,5例患者的胸段夹层假腔(n = 2)和动脉瘤囊(n = 3)完全消失。然而,在所有主动脉夹层患者中,腹主动脉的大小(P = .302)、形状均无明显变化,其假腔血流持续存在。12例患者(52%)术后即刻出现并发症;10例有发热、白细胞增多和C反应蛋白升高,另1例有伤口感染,还有1例有短暂腹痛。3例患者在术后2、3和12个月死亡:1例死于感染性休克,另1例死于潜在的纵隔炎,另1例死因不明。其余20例患者术后情况良好(1 - 9天;平均3天),无任何与支架移植物相关的并发症或不适(随访期:10 - 65个月;平均:25.1个月 ± 15.6)。支架置入术后30天的累积生存率为100%,12个月时为91%。
对于降主动脉夹层和囊状动脉瘤的治疗,血管内支架移植物修复术可能是一种技术上可行且有效的治疗方式。